Kallajoki M - Search Results

1

In vivo imaging of prostate cancer using [68Ga]-labeled bombesin analog BAY86-7548.

Kähkönen E, Jambor I, Kemppainen J, Lehtiö K, Grönroos TJ, Kuisma A, Luoto P, Sipilä HJ, Tolvanen T, Alanen K, Silén J, Kallajoki M, Roivainen A, Schäfer N, Schibli R, Dragic M, Johayem A, Valencia R, Borkowski S, Minn H. Kähkönen E, et al. Among authors: kallajoki m. Clin Cancer Res. 2013 Oct 1;19(19):5434-43. doi: 10.1158/1078-0432.CCR-12-3490. Epub 2013 Aug 9. Clin Cancer Res. 2013. PMID: 23935037 Free article.

2

Gene expression of group II phospholipase A2 in intestine in ulcerative colitis.

Haapamäki MM, Grönroos JM, Nurmi H, Alanen K, Kallajoki M, Nevalainen TJ. Haapamäki MM, et al. Among authors: kallajoki m. Gut. 1997 Jan;40(1):95-101. doi: 10.1136/gut.40.1.95. Gut. 1997. PMID: 9155583 Free PMC article.

3

Group II phospholipase A2 in human male reproductive organs and genital tumors.

Kallajoki M, Alanen KA, Nevalainen M, Nevalainen TJ. Kallajoki M, et al. Prostate. 1998 Jun 1;35(4):263-72. doi: 10.1002/(sici)1097-0045(19980601)35:4<263::aid-pros5>3.0.co;2-h. Prostate. 1998. PMID: 9609549

4

Cyclin A and Ki-67 with DNA content in benign and malignant prostatic epithelial lesions.

Mirtti T, Kallajoki M, Aaltonen M, Alanen K. Mirtti T, et al. Among authors: kallajoki m. Anal Quant Cytol Histol. 2001 Jun;23(3):229-37. Anal Quant Cytol Histol. 2001. PMID: 11444193

5

14(R,S)-[18F]Fluoro-6-thia-heptadecanoic acid as a tracer of free fatty acid uptake and oxidation in myocardium and skeletal muscle.

Takala TO, Nuutila P, Pulkki K, Oikonen V, Grönroos T, Savunen T, Vähäsilta T, Luotolahti M, Kallajoki M, Bergman J, Forsback S, Knuuti J. Takala TO, et al. Among authors: kallajoki m. Eur J Nucl Med Mol Imaging. 2002 Dec;29(12):1617-22. doi: 10.1007/s00259-002-0979-y. Epub 2002 Oct 3. Eur J Nucl Med Mol Imaging. 2002. PMID: 12458396

6

Expression of cystatins, high molecular weight cytokeratin, and proliferation markers in prostatic adenocarcinoma and hyperplasia.

Mirtti T, Alanen K, Kallajoki M, Rinne A, Söderström KO. Mirtti T, et al. Among authors: kallajoki m. Prostate. 2003 Mar 1;54(4):290-8. doi: 10.1002/pros.10196. Prostate. 2003. PMID: 12539227

7

Altered expression of syndecan-1 in prostate cancer.

Kiviniemi J, Kallajoki M, Kujala I, Matikainen MT, Alanen K, Jalkanen M, Salmivirta M. Kiviniemi J, et al. Among authors: kallajoki m. APMIS. 2004 Feb;112(2):89-97. doi: 10.1111/j.1600-0463.2004.apm1120202.x. APMIS. 2004. PMID: 15056224

8

Regulation of prostate cell collagen receptors by malignant transformation.

Mirtti T, Nylund C, Lehtonen J, Hiekkanen H, Nissinen L, Kallajoki M, Alanen K, Gullberg D, Heino J. Mirtti T, et al. Among authors: kallajoki m. Int J Cancer. 2006 Feb 15;118(4):889-98. doi: 10.1002/ijc.21430. Int J Cancer. 2006. PMID: 16152594

9

Group IIA phospholipase A as a prognostic marker in prostate cancer: relevance to clinicopathological variables and disease-specific mortality.

Mirtti T, Laine VJ, Hiekkanen H, Hurme S, Rowe O, Nevalainen TJ, Kallajoki M, Alanen K. Mirtti T, et al. Among authors: kallajoki m. APMIS. 2009 Mar;117(3):151-61. doi: 10.1111/j.1600-0463.2008.00002.x. APMIS. 2009. PMID: 19245588

10

Detection of melanoma-derived cancer-testis antigen CT16 in patient sera by a novel immunoassay.

Rappu P, Nylund C, Ristiniemi N, Kulpakko J, Vihinen P, Hernberg M, Mirtti T, Alanen K, Kallajoki M, Vuoristo MS, Pyrhönen S, Heino J. Rappu P, et al. Among authors: kallajoki m. Int J Cancer. 2011 May 15;128(10):2382-92. doi: 10.1002/ijc.25571. Int J Cancer. 2011. PMID: 20658534

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

111 results

Search Page

Filters